Dr. Stephen S. Nigh, MD

Dr. Nigh practices at Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health.

Dr. Nigh's NPI, 1396721874, was assigned on December 16, 2005. Dr. Nigh graduated from University of Kansas School of Med (KC/Wich/Sal) in 1987. Dr. Nigh holds Illinois license 036-110683.

Dr. Nigh's primary practice is Northwest Community Hospital, at 800 W Central Road, Arlington Heights, IL 60005 in Cook County. The practice phone is (847) 618-1000.

Dr. Nigh's primary practice is Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health. Dr. Nigh is also affiliated with Swedish Hospital. The medical group on file is Radiation Oncology Associates. Dmand AI also links Dr. Nigh to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nigh practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Nigh's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Nigh is licensed in Illinois.

CMS data shows 2,358 Medicare services from Dr. Nigh across 19 procedure codes in 2024, for 380 Medicare patients. Medicare paid $155,962 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 380 Medicare patients who saw Dr. Nigh in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have cancer, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nigh's median patient age at 72, with 79% women.

In 2024, Dr. Nigh wrote 42 Medicare Part D claims for 28 patients. 67% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $231 in total drug cost. In 2022, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Nigh for performance year 2024, reported individually. Dr. Nigh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Nigh in 2016. Dr. Nigh's most frequent co-authors are Deanna J. Attai, MD, Ben Hyung Han, MD and Kerri Lynn Perry, MD.

Dmand AI links Dr. Nigh to 8 clinical trials, 5 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Neoplasms, Male. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 24 general payments to Dr. Nigh from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $173.

Dr. Nigh graduated from University of Kansas School of Med (KC/Wich/Sal) in 1987.